POSITION SUMMARY: The regional Medical Science Liaison (MSL) serves as field-based medical resource for compliant scientific exchange on Rigel pipeline, areas of research, approved products, and associated disease states with healthcare providers, patient advocacy groups, payors, other industry partners, as well as internal colleagues at Rigel. The focus of the regional MSL will be on supporting Rigels approved oncology product for metastatic breast cancer but may require support of other approved products in hematology/oncology, as well as supporting any development or launch-related activities for Rigels pipeline, or in-licensed molecules.